The new whole-body magnetic resonance imaging (MRI) platform reportedly offers enhanced image quality and increased patient comfort.
Offering an array of advanced technologies, a newly FDA-approved magnetic resonance imaging (MRI) system may provide radiologists benefits across a variety of clinical applications.
Esaote North America said the Magnifico Open MRI device features metal artifact reduction (MAR), which can facilitate postoperative imaging for patients with metal implants. The system reportedly has a low level of susceptibility for metal in comparison to traditional MRI platforms, according to the company.
When it comes to sports-related injuries, Esaote North America noted the Magnifico Open MRI also has a “True-Motion” feature that allows for real-time imaging of a joint, according to the manufacturer.
In terms of image quality, the company said the Magnifico Open MRI has a high signal-to-noise ratio (SNR) and signal homogeneity that facilitate high spatial resolution.
Emphasizing patient comfort, the open platform may ease anxiety for children and patients with claustrophobia. Esoate North American also noted the device has a transparent head coil and laser alignment that enhance patient comfort and positioning.
“The Magnifico™ Open MRI is designed for patient comfort,” said Stephen Gibbs, the manager of MRI sales and marketing for Esaote North America. “With an open-gantry design, it is ideal for imaging children, large and claustrophobic patients. The compact size is uniquely suited for hospitals, imaging centers, and in-office clinics.”
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.